GKIM
DXCM icon

GW&K Investment Management’s DexCom DXCM Stock Holding History

GW&K Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16K Buy
239
+12
+5% +$799 ﹤0.01% 837
2026
Q1 		$14K Buy
227
+35
+18% +$2.44K ﹤0.01% 828
2025
Q4 		$13K Sell
192
-101
-34% -$6.53K ﹤0.01% 819
2025
Q3 		$20K Buy
293
+22
+8% +$1.74K ﹤0.01% 739
2025
Q2 		$24K Buy
271
+10
+4% +$784 ﹤0.01% 671
2025
Q1 		$18K Buy
261
+8
+3% +$653 ﹤0.01% 676
2024
Q4 		$20K Buy
253
+102
+68% +$7.55K ﹤0.01% 616
2024
Q3 		$10K Sell
151
-11
-7% -$903 ﹤0.01% 777
2024
Q2 		$18K Buy
162
+26
+19% +$3.29K ﹤0.01% 590
2024
Q1 		$19K Sell
136
-1
-0.7% -$126 ﹤0.01% 542
2023
Q4 		$17K Buy
137
+41
+43% +$4.19K ﹤0.01% 535
2023
Q3 		$9K Sell
96
-19
-17% -$2.14K ﹤0.01% 631
2023
Q2 		$15K Buy
115
+113
+5,650% +$13.7K ﹤0.01% 511
2023
Q1 		$0 Buy
+2
New +$224 ﹤0.01% 510
2022
Q3 		– Sell
-90
Closed -$7K – 524
2022
Q2 		$7K Buy
90
+34
+61% +$3.1K ﹤0.01% 512
2022
Q1 		$7K Buy
+56
New +$6.13K ﹤0.01% 467

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

GW&K Investment Management's DXCM Position: Q2 2026 in Review

GW&K Investment Management increased its DexCom (DXCM) stake by 5.3% in Q2 2026, buying an estimated $799 and bringing the position to 239 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #837.

GW&K Investment Management first reported a position in DXCM in Q1 2022 and has held it in 16 quarters since. The position peaked at $24K in Q2 2025. 975 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • GW&K Investment Management held 239 shares of DexCom worth $16K as of Q2 2026.
  • GW&K Investment Management bought 12 DexCom shares in Q2 2026, an estimated $799.
  • DexCom made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #837 holding.
  • GW&K Investment Management first reported a position in DexCom in Q1 2022 and has held it in 16 quarters since.
  • GW&K Investment Management's DexCom position peaked at $24K in Q2 2025.
  • 975 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.